Related references
Note: Only part of the references are listed.Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in Glioma
Xinxing Li et al.
MOLECULAR NEUROBIOLOGY (2016)
Aging and liver disease
In Hee Kim et al.
CURRENT OPINION IN GASTROENTEROLOGY (2015)
The long unfinished march towards understanding microRNA-mediated repression
Witold Filipowicz et al.
RNA (2015)
MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma
Jia-Yuan Huang et al.
ONCOTARGET (2015)
Age and sex differences in kidney microRNA expression during the life span of F344 rats
Joshua C. Kwekel et al.
BIOLOGY OF SEX DIFFERENCES (2015)
Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma
Chiao-Ling Li et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas
Michela Boi et al.
LEUKEMIA & LYMPHOMA (2015)
DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions
Ioannis S. Vlachos et al.
NUCLEIC ACIDS RESEARCH (2015)
Mir-152 inhibits cell proliferation and colony formation of CD133+ liver cancer stem cells by targeting KIT
Haili Huang et al.
TUMOR BIOLOGY (2015)
microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway
Jia Wang et al.
ONCOTARGET (2015)
DLK1-DIO3 imprinted cluster in induced pluripotency: landscape in the mist
Leonidas Benetatos et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Aberrant Hepatic MicroRNA Expression in Nonalcoholic Fatty Liver Disease
Yue Ying Feng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
miR-154*and miR-379 in the DLK1-DIO3 MicroRNA Mega-Cluster Regulate Epithelial to Mesenchymal Transition and Bone Metastasis of Prostate Cancer
Murali Gururajan et al.
CLINICAL CANCER RESEARCH (2014)
The miR-379/miR-410 cluster at the imprinted DlR1-Dio3 domain controls neonatal metabolic adaptation
Stephane Labialle et al.
EMBO JOURNAL (2014)
Female gender as a susceptibility factor for drug-induced liver injury
David E. Amacher
HUMAN & EXPERIMENTAL TOXICOLOGY (2014)
miRNA-183 Suppresses Apoptosis and Promotes Proliferation in Esophageal Cancer by Targeting PDCD4
Miao Yang et al.
MOLECULES AND CELLS (2014)
The p53/miR-34 axis in development and disease
Matjaz Rokavec et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2014)
Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration
Amelie Hailer et al.
ONCOTARGET (2014)
Influence of sex differences on microRNA gene regulation in disease
Salil Sharma et al.
BIOLOGY OF SEX DIFFERENCES (2014)
MicroRNAs as potential circulating biomarkers of drug-induced liver injury: key current and future issues for translation to humans
Robert James Hornby et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)
MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinoma
J. Zhang et al.
ONCOGENESIS (2014)
miRNA gene counts in chromosomes vary widely in a species and biogenesis of miRNA largely depends on transcription or post-transcriptional processing of coding genes
Atanu Ghorai et al.
FRONTIERS IN GENETICS (2014)
MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration
Pei Li et al.
BREAST CANCER RESEARCH (2014)
MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases
Yong He et al.
BIOCHIMIE (2013)
miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β
He-Ping Li et al.
CARCINOGENESIS (2013)
miR-203 inhibits proliferation of HCC cells by targeting survivin
Wang Wei et al.
CELL BIOCHEMISTRY AND FUNCTION (2013)
The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis
Leonidas Benetatos et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver
Hiroya Yamada et al.
CLINICA CHIMICA ACTA (2013)
Cardiac Expression of Deiodinase type 3 (Dio3) Following Myocardial Infarction Is Associated With the Induction of a Pluripotency microRNA Signature from the Dlk1-Dio3 Genomic Region
Rob Janssen et al.
ENDOCRINOLOGY (2013)
The role of miRNA-29 family in cancer
Yang Wang et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2013)
Circulating MicroRNAs as potential biomarkers for alcoholic steatohepatitis
Yi-peng Chen et al.
LIVER INTERNATIONAL (2013)
Sex Bias in Experimental Immune-Mediated, Drug-Induced Liver Injury in BALB/c Mice: Suggested Roles for Tregs, Estrogen, and IL-6
Joonhee Cho et al.
PLOS ONE (2013)
Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis
Po-Jen Chen et al.
HEPATOLOGY (2012)
Protective Role of Estrogen-induced miRNA-29 Expression in Carbon Tetrachloride-induced Mouse Liver Injury
Yaqin Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
MicroRNAs and their roles in aging
Thalyana Smith-Vikos et al.
JOURNAL OF CELL SCIENCE (2012)
miR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice
Jun Xiao et al.
MOLECULAR THERAPY (2012)
Sex differences in microRNA regulation of gene expression: no smoke, just miRs
Christopher P. Morgan et al.
BIOLOGY OF SEX DIFFERENCES (2012)
Serum miR-122 as a Biomarker of Necroinflammation in Patients With Chronic Hepatitis C Virus Infection
Verena Bihrer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
microRNAs: Master Regulators as Potential Therapeutics in Cancer
Michela Garofalo et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Function and Histopathology of a Cell Adhesion Molecule TSLC1 in Cancer
Qi-Lian Liang et al.
CANCER INVESTIGATION (2011)
Circulating microRNAs: Association with disease and potential use as biomarkers
Glen Reid et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Mechanisms and role of microRNA deregulation in cancer onset and progression
Edenir Ines Palmero et al.
GENETICS AND MOLECULAR BIOLOGY (2011)
MicroRNA-99a Inhibits Hepatocellular Carcinoma Growth and Correlates with Prognosis of Patients with Hepatocellular Carcinoma
Dong Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29
Wei Qin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1
Na Li et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2011)
Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease
Silvia Cermelli et al.
PLOS ONE (2011)
Age-associated changes in expression of small, noncoding RNAs, including microRNAs, in C. elegans
Masaomi Kato et al.
RNA (2011)
MicroRNAs and liver disease
Thomas A. Kerr et al.
TRANSLATIONAL RESEARCH (2011)
Comparative profiling of genes and miRNAs expressed in the newborn, young adult, and aged human epididymides
Jinsong Zhang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2010)
Regulation of mRNA Translation and Stability by microRNAs
Marc Robert Fabian et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
Age and sex dependent changes in liver gene expression during the life cycle of the rat
Joshua C. Kwekel et al.
BMC GENOMICS (2010)
miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma
Mayuko Furuta et al.
CARCINOGENESIS (2010)
MicroRNAs Both Promote and Antagonize Longevity in C-elegans
Alexandre de Lencastre et al.
CURRENT BIOLOGY (2010)
EPIGENETIC ALTERATIONS OF TUMOR MARKER MICRORNAs: TOWARDS NEW CANCER THERAPIES
Jia Wei et al.
DRUG NEWS & PERSPECTIVES (2010)
Risk Factors for Idiosyncratic Drug-Induced Liver Injury
Naga Chalasani et al.
GASTROENTEROLOGY (2010)
Activation of the Imprinted Dlk1-Dio3 Region Correlates with Pluripotency Levels of Mouse Stem Cells
Lei Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Making RISC
Tomoko Kawamata et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Phenotypic Characterization of Idiosyncratic Drug-Induced Liver Injury: The Influence of Age and Sex
M. Isabel Lucena et al.
HEPATOLOGY (2009)
miRecords: an integrated resource for microRNA-target interactions
Feifei Xiao et al.
NUCLEIC ACIDS RESEARCH (2009)
Circulating microRNAs, potential biomarkers for drug-induced liver injury
Kai Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Emerging role of microRNAs in liver diseases
Shashi Bala et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Inpatient admissions for drug-induced liver injury: Results from a single center
Elizabeth J. Carey et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Murine microRNAs implicated in liver functions and aging process
Olivier C. Maes et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2008)
BLIMP1 guides the fate of effector B and T cells
Stephen L. Nutt et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
Willscott E. Naugler et al.
SCIENCE (2007)
Growth hormone regulation of sex-dependent liver gene expression
David J. Waxman et al.
MOLECULAR ENDOCRINOLOGY (2006)
Structural basis for double-stranded RNA processing by dicer
IJ MacRae et al.
SCIENCE (2006)
Prevalence of appropriate and problematic antiepileptic combination therapy in older people in the nursing home
SL Harms et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Liver transplantation for acute liver failure from drug induced liver injury in the United States
MW Russo et al.
LIVER TRANSPLANTATION (2004)
The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children
TN Johnson
TOXICOLOGY (2003)
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States
G Ostapowicz et al.
ANNALS OF INTERNAL MEDICINE (2002)
MicroRNA maturation: stepwise processing and subcellular localization
Y Lee et al.
EMBO JOURNAL (2002)
Children versus adults: Pharmacokinetic and adverse-effect differences
GD Anderson
EPILEPSIA (2002)
Assessing risk to benefit ratio in antiepileptic drug therapy
E Perucca et al.
EPILEPSY RESEARCH (2000)
Share Paper
